| American Society of Hematology--51st annual meeting & exposition. Part 2. | |
| | |
MedLine Citation:
|
PMID: 20127550 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 51st Annual Meeting & Exposition of the American Society of Hematology, held in New Orleans, included topics covering new therapeutic developments in the field of hematology. This conference report highlights selected presentations on combination regimens for the treatment of multiple myeloma, selected kinase inhibitors and a recombinant HOXB4 protein. Investigational drugs discussed include SB-1518 (S*Bio Pte Ltd) and PF-2341066 (Pfizer Inc). |
| | |
Authors:
|
Jaya Shumoogam; Natasher Beecher |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 13 ISSN: 2040-3410 ISO Abbreviation: IDrugs Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-02-03 Completed Date: 2010-04-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 60-2 Citation Subset: IM |
Affiliation:
|
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. jaya.shumoogam@thomsonreuters.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antineoplastic Combined Chemotherapy Protocols / pharmacology Drugs, Investigational / pharmacology* Humans Multiple Myeloma / drug therapy* Protein Kinase Inhibitors / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Investigational; 0/Protein Kinase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: American Society of Hematology - 51st Annual Meeting & Exposition. Part 1.
Next Document: European Society of Gene & Cell Therapy - 17th Annual Congress.